JPWO2023079954A1 - - Google Patents

Info

Publication number
JPWO2023079954A1
JPWO2023079954A1 JP2023557936A JP2023557936A JPWO2023079954A1 JP WO2023079954 A1 JPWO2023079954 A1 JP WO2023079954A1 JP 2023557936 A JP2023557936 A JP 2023557936A JP 2023557936 A JP2023557936 A JP 2023557936A JP WO2023079954 A1 JPWO2023079954 A1 JP WO2023079954A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557936A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023079954A1 publication Critical patent/JPWO2023079954A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14Yeasts or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Volume Flow (AREA)
JP2023557936A 2021-11-08 2022-10-19 Pending JPWO2023079954A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021181678 2021-11-08
PCT/JP2022/038850 WO2023079954A1 (ja) 2021-11-08 2022-10-19 内耳性難聴の抑制又は予防のためのエルゴチオネインを含む組成物

Publications (1)

Publication Number Publication Date
JPWO2023079954A1 true JPWO2023079954A1 (https=) 2023-05-11

Family

ID=86240934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557936A Pending JPWO2023079954A1 (https=) 2021-11-08 2022-10-19

Country Status (6)

Country Link
US (1) US20250108037A1 (https=)
EP (1) EP4431095A4 (https=)
JP (1) JPWO2023079954A1 (https=)
CN (1) CN118215476A (https=)
TW (1) TW202327585A (https=)
WO (1) WO2023079954A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118319905A (zh) * 2024-04-24 2024-07-12 中国药科大学 麦角硫因在制备预防和降低耳损伤和改善听力药物的应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009249356A (ja) * 2008-04-08 2009-10-29 Daicel Chem Ind Ltd エルゴチオネインの製造方法
JP2011037738A (ja) * 2009-08-08 2011-02-24 Chube Univ 難聴又は耳鳴りの予防・治療剤
JP2014223051A (ja) * 2012-07-13 2014-12-04 タカラバイオ株式会社 エルゴチオネインの製造方法
US9437472B2 (en) * 2014-02-27 2016-09-06 Taiwan Semiconductor Manufacturing Company Ltd. Semiconductor line feature and manufacturing method thereof
JP2018515065A (ja) * 2016-01-04 2018-06-14 グレープ キング バイオ エルティーディー.Grape King Bio Ltd. 聴覚低下を予防するための活性物質、活性物質を含む組成物及びその調製方法
JP2021138640A (ja) * 2020-03-04 2021-09-16 長瀬産業株式会社 L−エルゴチオネイン含有組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5421366B2 (ja) 2008-07-21 2014-02-19 オトノミ―,インク. 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US11390897B2 (en) * 2014-12-22 2022-07-19 National University Corporation Okayama University Method for producing ergothioneine
JP6758703B2 (ja) * 2016-06-21 2020-09-23 国立大学法人 岡山大学 エルゴチオネインの産生方法
JP7033789B2 (ja) * 2016-06-29 2022-03-11 オトノミー,インク. トリグリセリド耳用製剤とその使用
JP7529255B2 (ja) * 2019-10-17 2024-08-06 株式会社エル・エスコーポレーション 認知機能速度改善用の組成物

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009249356A (ja) * 2008-04-08 2009-10-29 Daicel Chem Ind Ltd エルゴチオネインの製造方法
JP2011037738A (ja) * 2009-08-08 2011-02-24 Chube Univ 難聴又は耳鳴りの予防・治療剤
JP2014223051A (ja) * 2012-07-13 2014-12-04 タカラバイオ株式会社 エルゴチオネインの製造方法
US9437472B2 (en) * 2014-02-27 2016-09-06 Taiwan Semiconductor Manufacturing Company Ltd. Semiconductor line feature and manufacturing method thereof
JP2018515065A (ja) * 2016-01-04 2018-06-14 グレープ キング バイオ エルティーディー.Grape King Bio Ltd. 聴覚低下を予防するための活性物質、活性物質を含む組成物及びその調製方法
JP2021138640A (ja) * 2020-03-04 2021-09-16 長瀬産業株式会社 L−エルゴチオネイン含有組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LWT - FOOD SCIENCE AND TECHNOLOGY, vol. 47, JPN6024046808, 2012, pages 274 - 278, ISSN: 0005802348 *
食品と開発, vol. 55, no. 10, JPN7024004909, 2020, pages 78 - 79, ISSN: 0005802347 *

Also Published As

Publication number Publication date
EP4431095A4 (en) 2025-03-26
CN118215476A (zh) 2024-06-18
TW202327585A (zh) 2023-07-16
EP4431095A1 (en) 2024-09-18
WO2023079954A1 (ja) 2023-05-11
US20250108037A1 (en) 2025-04-03

Similar Documents

Publication Publication Date Title
BR112023012656A2 (https=)
BR112023009656A2 (https=)
JPWO2021177397A1 (https=)
JPWO2023079954A1 (https=)
BR112023011738A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021015220A2 (https=)
BR102021014056A2 (https=)
BR102021014044A2 (https=)
BR102021013929A2 (https=)
BR102021012230A2 (https=)
BR102021012107A2 (https=)
BR102021012003A2 (https=)
BR112023008622A2 (https=)
CN305530689S (https=)
CN305528834S (https=)
CN305533348S (https=)
CN305533095S (https=)
CN305531968S (https=)
CN305531560S (https=)
CN305531310S (https=)
CN305534562S (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240912

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20240912

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241120

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250617

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250716

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251002

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260224